t e C h n I C a l r e p O r t S Protein translation has been implicated in different forms of synaptic plasticity, but direct in situ visualization of new proteins is limited to one or two proteins at a time. Here we describe a metabolic labeling approach based on incorporation of noncanonical amino acids into proteins followed by chemoselective fluorescence tagging by means of 'click chemistry'. After a brief incubation with azidohomoalanine or homopropargylglycine, a robust fluorescent signal was detected in somata and dendrites. Pulse-chase application of azidohomoalanine and homopropargylglycine allowed visualization of proteins synthesized in two sequential time periods. This technique can be used to detect changes in protein synthesis and to evaluate the fate of proteins synthesized in different cellular compartments. Moreover, using strain-promoted cycloaddition, we explored the dynamics of newly synthesized membrane proteins using single-particle tracking and quantum dots. The newly synthesized proteins showed a broad range of diffusive behaviors, as would be expected for a pool of labeled proteins that is heterogeneous.
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The visualization of a newly synthesized proteome has been hindered so far by the fact that proteins, new and old, share the same pool of amino acids and thus are chemically indistinguishable. Radioisotopically labeled amino acids can provide potent labeling of newly synthesized proteins, but the subsequent visualization of new proteomes in intact cells is not well resolved or amenable to current fluorescence microscopy techniques.
The proteome of a neuron is a dynamic entity, tightly regulated by protein synthesis and degradation to maintain homeostasis or to adapt to changing environmental conditions. Many studies of behavioral and synaptic plasticity have demonstrated that long-lasting changes in synaptic transmission and behavior require both gene transcription and mRNA translation (reviewed in ref. 1) . Indeed, a distinguishing feature of late-phase long-term potentiation is that it requires both gene transcription and mRNA translation (for example, ref.
2). Protein synthesis occurs in somata as well as in the protrusions of neurons and other polarized cells. In neurons, there is abundant evidence from both in vivo and in vitro experiments that dendritic protein synthesis is used to allow neuronal synapses to respond dynamically and specifically to the stimulation patterns that drive the establishment, maintenance and plasticity of synaptic connections [3] [4] [5] [6] . Moreover, several studies have demonstrated that various biochemical fractions lacking somatic protein synthesis machinery are nonetheless capable of synthesizing proteins (see refs. 7,8 for review), and several proteomics studies have identified proteins belonging to different functional classes [9] [10] [11] . Despite overwhelming support for the general notion of dendritic protein translation in plasticity and synaptic function, local protein translation has been monitored so far for only a few candidate proteins. Visualization of newly synthesized proteins in neurons has largely relied on the use of green fluorescent protein (GFP)-either as a fusion with the protein of interest or with the coding sequence for GFP flanked by the 5′ and 3′ untranslated regions (to confer regulation of mRNA translation) of the protein of interest [12] [13] [14] -or a proteasecontrolled tag 15 . All of these approaches require overexpression of the coding sequence and/or the regulatory regions of the mRNA. Recent work [16] [17] [18] [19] , however, has expanded the natural repertoire of amino acids and introduced small, bio-orthogonal groups that are metabolically incorporated into nascent proteins, enabling pulselabeling of a set of new proteins 20 .
We recently described the use of the azide-bearing amino acid azidohomoalanine (AHA) or the alkyne-bearing amino acid homopropargylglycine (HPG) for incorporation into new proteins by making use of the cell's own protein synthesis machinery; this technology is called BONCAT (bio-orthogonal noncanonical amino acid tagging 21, 22 ). In BONCAT the methionine surrogate AHA is incorporated into newly synthesized proteins at methionine codons and subsequently tagged with an alkyne-affinity tag by means of copper-catalyzed azide-alkyne [3+2] cycloaddition (CuAAC; ref. 23) for the ultimate identification of AHA-labeled proteins using mass spectrometry. Here we introduce, using a new generation of fluorescent tags, a sister technology to BONCAT that labels and enables the visualization of a broad spectrum of newly synthesized neuronal proteins in situ using conventional fluorescence microscopy. We name this visualization approach FUNCAT (fluorescent noncanonical amino acid tagging).
t e C h n I C a l r e p O r t S RESULTS Fluorescence in situ tagging of newly synthesized proteins Given limited existing methods, we sought to develop a methodology for the in situ visualization of newly synthesized proteins using fluorescence microscopy. Building on the core chemistry of BONCAT and using as a linker polyethylene oxide (PEO), we synthesized two different fluorescent tags (Texas Red-PEO 2 -alkyne, TRA; 5′-carboxyfluorescein-PEO 8 -azide, FLA) that can be coupled to AHA-or HPG-bearing proteins using 'click chemistry' 23 (Fig. 1a,b and Supplementary Fig. 1 ). The use of the water-soluble PEO linker simplifies the tag synthesis, making it tractable in a biology laboratory setting 18 , and also maximizes the signal-to-noise ratio of the fluorescent label, as any unligated tag is easily removed by washes.
We optimized the labeling and reaction conditions to maximize the specific detection of newly synthesized proteins in situ and to permit immunolabeling. To maximize charging and incorporation of the methionine surrogates AHA or HPG, we removed growth medium from the preparations and replaced it with HEPES-buffered solution (HBS) or methionine-free Hibernate A (HibA) medium for 30 min before addition of AHA or HPG. After bath application of either AHA or HPG, we fixed and permeabilized neurons using Triton X-100. After overnight incubation in a reaction mixture that included the fluorescent tag, the copper catalyst and the triazole ligand, we visualized (Fig. 1b) newly synthesized proteins using conventional fluorescence microscopy. Incubation of primary hippocampal neurons with AHA or HPG for 1 h (in the absence of methionine) resulted in abundant labeling of newly synthesized proteins in somata and dendritic processes (Fig. 2a, first and third rows from top) at comparable levels in either AHA-or HPG-treated neurons. When protein synthesis was prevented by coapplication of the protein synthesis inhibitor anisomycin, the fluorescent signal was markedly reduced (Fig. 2a, second and fourth rows from top) confirming that this procedure labeled newly synthesized proteins with high specificity. Moreover, to further test the specificity of the approach, we either omitted the copper catalyst in the click reaction mixture or coapplied methionine at an equimolar concentration, which prevented detection or incorporation, respectively, of AHA-and HPG-derived signals (Supplementary Fig. 2 ). After the click reaction, neurons can also be processed for conventional immunocytochemistry; we demonstrated this by immunolabeling with the dendritic marker MAP2 in AHA-or HPG-treated neurons (Fig. 2a) . The combination of FUNCAT with immunolabeling did not alter the FLA or TRA signal intensity or result in cross-talk of the red and green image acquisition channels.
After a 1-h incubation with either AHA or HPG, newly synthesized proteins were detected in both the somata and dendrites. Longer (~2 h) exposures to AHA or HPG revealed the presence of newly synthesized proteins in spine-like protrusions from dendrites (Fig. 2b) . This signal is likely to represent the presence of newly synthesized proteins at synapses, as evidenced by proximity to the presynaptic protein Bassoon. Notably, we did not detect any changes in neuronal morphology in somata or dendrites, nor elevated incidence of cell death, indicating lack of apparent toxicity resulting from AHA and HPG incubation for any concentration or methionine starvation period tested (see also ref. 22) . Taken together, these data indicate that noncanonical amino acids coupled t e C h n I C a l r e p O r t S to fluorescent tags by means of click chemical reactions can be used to visualize newly synthesized proteins with high specificity. We next examined whether visualization of newly synthesized proteins could be performed in intact tissue using organotypic hippocampal slices. We increased the duration of exposure to AHA (to 4 h) to allow penetration of the amino acid into the depth of the slice (~150 μm thick). AHA-tagged proteins were present in somata and dendrites throughout the entire slice after labeling with AHA for 4 h (Supplementary Fig. 3) . Application of the protein synthesis inhibitor anisomycin (40 μM) together with AHA completely blocked the fluorescent signal, indicating that protein synthesis was required for the fluorescence visualization. The combination of FUNCAT with immunolabeling for MAP2 showed that newly synthesized proteins detected in organotypic slices were present in both the cell bodies and the dendrites of hippocampal neurons (Supplementary Fig. 3 ). The remaining FUNCAT signal not accounted for by the somatic and dendritic label likely was due to new protein synthesis in axons and glia, on the basis of immunostaining experiments using the axonal marker tau ( Supplementary  Fig. 4 ) or the astroglial marker GFAP in dissociated cortical cultures (D.C.D., unpublished observations).
To examine the effects of a particular treatment on a proteome, it is often desirable to conduct pulse-chase experiments in which two different time intervals can be examined. As there are two different noncanonical amino acids available, we investigated the feasibility of sequential application of AHA and HPG, followed by a click reaction with their complementary fluorescent TRA and FLA tags. There were two main considerations in adapting the technique for two intervals of labeling: first, optimization of the loading and incorporation of both AHA and HPG and, second, optimization of the tag brightness, taking into consideration bleaching and the extended period of time from labeling to imaging. We tested all possible sequences of labeling (first AHA then HPG, or first HPG then AHA) and detection (TRA or FLA tag). For example, neurons were treated with HPG for 1 h and then washed and treated with AHA for 1 h. After AHA treatment, neurons were fixed and exposed first to the FLA tag (overnight), followed by thorough rinses with EDTA-free PBS to remove unligated tag, and then exposed to the TRA tag (again, overnight) (or vice versa). This resulted in the fluorescence labeling of two distinct proteomes, synthesized in sequential time periods (Fig. 3) . Labeling was completely abolished if anisomycin was present during the application of AHA and HPG (data not shown). We analyzed the TRA and FLA signals in both the somatic and dendritic compartments and compared the label intensities for the different labeling orders. Application of HPG before labeling with AHA yielded the brightest and most consistent labeling (see also Supplementary Fig. 5 ); this fits with in vitro observations that charging of HPG onto methionyl tRNA is slower than charging of AHA 16 . Therefore, by using HPG in the first pulse followed by AHA in the second pulse, the effect of the slower HPG charging rate may be diminished. In addition, we determined that ligation of the TRA tag before the FLA tag is preferable, most likely because the Texas Red dye is less prone to photodegradation and bleaching than the fluorescein fluorophore 24 , a factor that might be overcome by using fluorophores with the same stability features. Thus, the optimal sequential tagging strategy for labeling two intervals of protein synthesis is HPG, then AHA, then TRA, then FLA. This approach, coupled with a period of stimulation, should provide a means to visualize changes in neuronal protein synthesis.
Sensitivity of FUNCAT
To investigate how quickly newly synthesized proteins can be visualized, we performed a time-course experiment, varying the duration of exposure to either AHA or HPG. To capture early translation events, we imaged neurons with high resolution after FUNCAT and MAP2 immunostaining. We analyzed the signal intensities of newly synthesized proteins of straightened images of dendrites using the MAP2-defined area as a mask. Notably, newly synthesized proteins can be detected in neuronal somata after a brief, 10-min AHA or HPG exposure (Fig. 4a,b and Supplementary Fig. 6 , respectively). Increasing the duration of AHA or HPG exposure resulted in a more intense fluorescent signal in cell bodies and the emergence of signal in the dendrites. Newly synthesized proteins in proximal dendrites were visible as early as 20 min after incubation (Fig. 4c,d) , with signals increasing in intensity and expanding into distal dendritic segments within 2 h. We compared the relative efficacy of AHA and HPG and found no difference in tagging performance for AHA or HPG for time points over 30 min. However, for early time points t e C h n I C a l r e p O r t S (10 min and 20 min), AHA seemed to be incorporated faster into nascent proteins than did HPG, again consistent with previously published charging rates of AHA and HPG by the methionyl-tRNA synthetase (MetRS) 16 .
Protein translation enables neurons to respond rapidly to changes in the environment or activity pattern. Brain-derived neurotrophic factor (BDNF) is an important modulator of neuronal activity during development as well as in the adult organism, and has been implicated in regulation of neuronal survival, signaling and activity-dependent synaptic plasticity 25 . Moreover, it has been shown that BDNF elicits a protein synthesis-dependent enhancement of synaptic strength 5, 12 . In addition, BDNF induces an increase in dendritic translation of a GFP-based reporter construct in mechanically and optically isolated dendrites 12 . To examine the effects of synaptic stimulation on protein translation and on the localization of newly synthesized proteins, we performed bath application experiments with BDNF in the presence of AHA, followed by detection of AHA-harboring proteins with FUNCAT. After bath application of BDNF (50 ng ml −1 ) for 1 h, we detected a signal of newly synthesized proteins in proximal segments of BDNF-treated dendrites 1.6-fold greater than that in vehicletreated controls (Fig. 5a,b) . In these experiments, the distal dendrites showed only modest BDNF-induced increases in translation, which may be attributed to the low signal-to-noise ratio associated with fluorescence imaging in tiny processes. These data demonstrate that FUNCAT can be used to visualize changes in protein synthesis in intact neurons. t e C h n I C a l r e p O r t S Exploring the site of translation The above experiments, in which AHA or HPG was introduced in the bath, do not address the site (somata or dendrites) of protein synthesis. To examine dendritic protein synthesis in a context where somatic synthesis is minimized, we locally perfused a protein synthesis inhibitor over a neuronal cell body while AHA was applied to the bath. To examine whether the noncanonical amino acids can be taken up across dendritic membranes and locally incorporated into proteins, we examined the localization of the amino acid transporter LAT1 and MetRS. Both proteins were detected in the somata and dendrites, showing a punctate distribution pattern ( Supplementary  Fig. 7) . Using small delivery and suction pipettes, we microperfused anisomycin over the soma while AHA was bath-applied in the presence or absence of BDNF (Fig. 6a) . Thirty minutes after addition of AHA (or AHA plus BDNF) to the bath, we fixed and processed cells for FUNCAT staining and MAP2 immunostaining. As previously observed, in the absence of somatic anisomycin perfusion, BDNF enhanced the new protein synthesis signal in both the cell bodies and the dendrites (Fig. 6b,c) . We then addressed the contribution of somatic protein synthesis to this enhancement by introducing the perfusion of anisomycin over cell bodies. The somatic perfusion of anisomycin diminished the signal intensity of newly synthesized proteins in the soma to levels comparable to those observed when anisomycin and AHA were bath applied (Fig. 6b) . These data suggest that the local somatic perfusion of anisomycin is as effective as bath application in inhibiting somatic protein synthesis. Notably, the distal segments of dendrites from neurons perfused at the soma with anisomycin showed AHA-derived intensity levels that were comparable to those in dendrites from unperfused neurons (Fig. 6c,d) , suggesting a dendritic synthesis source for this AHA-derived signal.
Moreover, as observed previously (for example, Fig. 5) , the addition of BDNF resulted in an increase in translation over the entire dendrite. Statistical analysis (one-way analysis of variance (ANOVA) with post hoc Tukey multiple-comparison testing) revealed significant main effects of both treatment and dendritic segment; the interaction was also significant (P ≤ 0.05).
To examine directly whether noncanonical amino acids can be locally incorporated into proteins synthesized in dendrites, we selectively microperfused AHA onto single distal dendrites (Fig. 7a) .
In these experiments, we combined local dendritic microperfusions with bath application of anisomycin to reduce the likelihood of two events: (i) AHA incorporation into proteins at sites adjacent to the dendritic perfusion area (owing to possible intracellular diffusion of AHA; Fig. 7b ) and (ii) retrograde transport of AHA to the soma followed by incorporation of AHA into somatically synthesized proteins. When compared to absence of dendrite perfusion (Fig. 7b,c) , the local perfusion of AHA led to detectable de novo protein synthesis in dendrites, inside as well as outside the perfused area. Signal for newly synthesized proteins, however, was more prominent within the perfused area, with a slight gradient of increased intensity toward the soma. The latter observation might be explained by retrograde transport of AHA-labeled proteins to the soma (synapse-tonucleus communication) as well as the geometrical properties of the dendrite itself. As predicted, co-perfusion of AHA and BDNF (50 ng ml −1 ) resulted in an increase in dendritic translation (ranging from 1.2-to 1.7-fold). Moreover, newly synthesized proteins were found to a larger extent in regions adjacent to the perfused area, indicating that local application of the neurotrophin also may affect the translation in or diffusion to neighboring synaptic regions. To exclude the possibility that local microperfusion itself exerts these effects, 
t e C h n I C a l r e p O r t S
we repeated the last experiment in combination with AHA bath application (Supplementary Fig. 8) . Here, microperfusion of AHA results in negligible changes in protein translation, whereas local coapplication of BDNF produced a pronounced increase in de novo protein synthesis.
Diffusion properties of new proteins at neuronal membranes
In the previous experiments, the copper-dependent click reaction that couples the newly synthesized proteins to our fluorescent tags required fixation of the sample. We next analyzed the mobility of individual newly synthesized proteins in the membrane of living neurons, using single-particle tracking experiments in which quantum dots were coupled to membrane proteins tagged with AHA (Fig. 8a) . Given their brightness and photostability, quantum dot nanoparticles are powerful fluorescent probes for single-particle tracking 26 . After a brief (~30 min) methionine deprivation, neurons were incubated with AHA, methionine or AHA + anisomycin for 2-4 h to allow new proteins to be synthesized and trafficked to the cell surface. The detection of AHA-labeled proteins in living cells involved the use of a copper-free click chemistry method 27 based on the covalent coupling of the azide group of AHA-tagged proteins with an alkynebearing reagent-a difluorinated cyclooctyne (DIFO), a membraneimpermeant reagent. Subsequently, neurons were incubated in a DIFO-biotin derivative, washed and labeled with streptavidinconjugated quantum dots for 1 min.
Quantum dot labeling in living and unpermeabilized cells resulted in newly synthesized AHA-containing, quantum dot-associated proteins detected both on neurites and somata (Fig. 8b) . The quantum dot labeling was specific, as very few quantum dots were associated with the neuronal surface in control conditions.
We characterized the motions of quantum dot-labeled proteins (Fig. 8c) after trajectory reconstruction, and determined their relationship to synapses with FM4-64 staining (Fig. 8c) . The high signalto-noise ratio of quantum dots enables estimation of their position with an accuracy of 10-20 nm (ref. 28) . The plot of the mean square displacement (MSD) as a function of time indicates the type of movement: at the extrasynaptic membrane, newly synthesized proteins had a Brownian-like behavior, as indicated by the almost linear MSDversus-time plot; at synapses, the movement was confined, as the plot tended toward an asymptote (Fig. 8d) . The cumulative distribution of diffusion coefficients (D) of newly synthesized proteins emphasizes the heterogeneity of diffusive behaviors. D values spread over five orders of magnitude (10 −4 < D < 1 μm 2 s −1 ), with a bimodal distribution (Fig. 8e,f) , likely reflecting the diversity of newly synthesized proteins. At extrasynaptic regions, a fast-moving population (2.5 × 10 −2 < D < 1 μm 2 s −1 ) represented 50% of the trajectories, and a slow one (D < 10 −3 μm 2 s −1 ) represented 35% of the trajectories. AHA-tagged proteins were slower at synapses than outside synapses, with similar numbers of immobile quantum dots (65% and 50%, respectively).
We compared the D distribution of the population of newly synthesized proteins to those of defined membrane proteins, such as the γ2-GABA A receptor subunit in hippocampal neurons at 15 days in vitro (DIV) (Fig. 8e,g ). t e C h n I C a l r e p O r t S 6.10 −2 μm 2 s −1 , spanning only a subrange of that of the whole pool of newly synthesized proteins. This was also the case for glycosyl phosphatidylinositol-anchored GFP 29 , the GluR5 metabotropic glutamate receptor 30, 31 and the GluR2 AMPA receptor 32 . Each individual protein had a specific pattern of mobility, which is reflected in the distribution of the diffusion coefficients; the diffusion coefficient of the newly synthesized proteins, in contrast, spanned the distribution of any individual protein (Fig. 8f) . Other parameters such as confinement and dwell time in given compartments were distinct as well (data not shown).
DISCUSSION
Synapses possess a complex mixture of proteins including receptors and regulatory and scaffolding proteins. Despite a clear need, a method for dynamic visualization of the complete dendritic and/or synaptic proteome is still lacking. Indeed, new protein synthesis during synaptic plasticity is often inferred from electrophysiological recordings, rather than directly visualized or detected [4] [5] [6] 33, 34 . In a few cases, however, the direct visualization of a single type of newly synthesized protein has been achieved with great effort 12, 14, 35, 36 . Owing to the techniques used (fluorescent reporters or antibodies) these studies have necessarily focused on one or two candidate proteins at a time.
Bio-orthogonal chemistry provides an alternative to these methods, as it lends new functionality to endogenous proteins using chemical groups that are not readily found in living organisms. We demonstrate that a brief (~10 min) application of either AHA or HPG followed by a click reaction with a fluorescent (azide-or alkyne-bearing) tag gives rise to a clearly detectable signal in neuronal somata. A slightly longer (~20 min) exposure to AHA or HPG allows visualization of newly synthesized proteins in dendrites. To visualize newly synthesized proteins, we developed two fluorescent alkyne probes, TRA and FLA, for ligation to AHA-or HPG-labeled proteins. A previous study used HPG together with a 3-azido-7-hydroxycoumarin tag to visualize newly synthesized proteins in heterologous cells 37 . The TRA and FLA tags are better for tagging newly synthesized proteins in dissociated neuronal cultures and organotypic slices than are the coumarin dye because there is less background labeling associated with the tag sticking to the poly-d-lysine coating of the dishes used for culturing dissociated neurons. The synthesis can be easily adapted to develop similar PEO-linked tags using different fluorophores to accommodate special needs such as those of STED high-resolution microscopy. In addition, the recent development of alkyne tags that can be coupled to azides by means of strain-promoted cycloaddition 38 enabled us to examine the spatial dynamics of de novo synthesized membrane proteins in real time. The specific compartment where proteins are synthesized is important for understanding both the cell biology and the logic of synaptic function and plasticity. Using microperfusion techniques to effect the selective exposure of somata or dendrites to AHA and/or a protein synthesis inhibitor, we observed the spatial origin of the newly synthesized proteins in both cell bodies and dendrites. In future studies this technique could be used to visualize the trafficking and destination of proteins synthesized in distinct neuronal compartments. Here, the use of microfluidic cell culture devices 39 to accommodate the spatially restricted delivery of metabolites and reagents may allow investigation of the contributions of somatic and dendritic protein synthesis to synaptic plasticity. For example, there is considerable interest in the idea of 'synaptic tagging' whereby synaptic signals stimulate transcription and/or translation in the soma and the mRNAs or proteins generated are then 'captured' at those synapses that have been tagged. Thus far, the capture of new proteins has been inferred by clever electrophysiological and pharmacological manipulations 4, 6, [40] [41] [42] . The techniques described here would allow one to directly visualize the capture phenomenon.
As the technique works both in dissociated neurons and in brain slices, labeling in vivo may also be possible. In this case, the ability to label subpopulations of neurons has distinct advantages for both visualization and circuit analysis. We have recently described a new system that may permit such visualization 43 . In this system, a mutant version of MetRS is introduced that incorporates a modified noncanonical amino acid (azidonorleucine) into protein. Cell-or promoterspecific labeling can be effected by the selective expression of the mutant MetRS in a particular cell population; azidonorleucine is not charged by the endogenous MetRS and, as such, will only label proteins in the identified cell population.
The earliest demonstrations that new protein synthesis is important for long-term memory were behavioral studies in both rodents 44 and fish 45 . Using modifications of the techniques we describe above, we should be able to visualize, directly, protein synthesis in neural circuits involved in learning and memory.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
ONLINE METHODS
Reagents. We purchased all reagents at ACS grade from Sigma unless noted otherwise. We purchased BDNF from Promega and used it at a concentration of 50 μg ml −1 . We purchased HPG from Chiralix. organic synthesis. We prepared AHA and the triazole ligand as described previously 47 . We prepared the Texas Red-PEO 2 -alkyne by dissolving Texas Red-PEO 2 -propionic acid succinimidyl ester (Biotium) in excess neat propargylamine (Sigma-Aldrich). After 30 min, we added the solution dropwise to anhydrous diethyl ether. We collected the resulting precipitate by centrifugation (5 min, 10 °C, 10,000g). Then we washed the precipitate three times with anhydrous diethyl ether, dried it and characterized it by ion spray mass spectrometry to confirm the formation of the product with a molecular weight of 802.90 g mol −1 (Supplementary Fig. 1a) . We synthesized the azide-bearing fluorescein tag in a similar way using the amine-reactive 5-carboxyfluorescein-PEO 8 -propionic acid succinimidyl ester (Biotium Inc.) and 3-azidopropan-1-amine 20 to yield a product with a molecular weight of 881.20 g mol −1 (Supplementary Fig. 1b) . cultured hippocampal neuron and organotypic hippocampal cultures. We prepared and maintained dissociated hippocampal neurons as previously described 12 . Briefly, we dissected out hippocampi from postnatal day 0 to 2 rat pups (strain Sprague-Dawley), dissociated them with either trypsin or papain, and plated cells at a density of 40,000 per cm 2 onto poly-d-lysine-coated glass-bottom Petri dishes (Mattek). We maintained these cultures in Neurobasal A medium containing B-27 and Glutamax supplements (Invitrogen) at 37 °C for 18-24 days before use. We prepared organotypic hippocampal cultures as previously described 48 and maintained them in culture for 3 weeks before use.
copper-catalyzed [3+2] azide-alkyne cycloaddition chemistry and detection of tagged proteins.
In all culture experiments, we removed the growth medium from neuronal cultures and replaced it with either HBS 12 or methionine-free HibA medium (BrainBits LLC) for 30 min to deplete endogenous methionine. We observed no difference in protein synthesis between neuronal cultures incubated in HBS or HibA for time points tested (up to 2 h). However, we opted to use HibA after it became available as a defined and customizable minimal neuronal growth media to optimize and standardize our labeling procedure. For AHA labeling, we supplemented HBS and HibA with 2 mM AHA, 2 mM AHA plus 40 μM anisomycin, or 2 mM methionine. After incubation at 37 °C, 5% CO 2 , we washed cells with chilled PBS-MC (1mM MgCl 2 , 0.1 mM CaCl 2 in PBS) on ice to remove excess amounts of AHA and methionine, followed by immediate fixation with chilled 4% paraformaldehyde, 4% sucrose in PBS-MC for 20 min at room temperature (20-25 °C) .
For CuAAC, to avoid copper bromide-derived precipitates, we used tris (2-carboxyethyl)phosphine (TCEP) in combination with copper sulfate to generate the Cu(i) catalyst during the CuAAC reaction. Briefly, a CuAAC reaction mix composed of 200 μM triazole ligand (stock solution dissolved at 200 mM in DMSO), 2 μM fluorescent alkyne or azide tag, 400 μM TCEP and 200 μM CuSO 4 was mixed in PBS, pH 7.6, with vigorous vortexing after each addition of a reagent. We incubated hippocampal primary cultures or organotypic hippocampal slices overnight at 20 °C with the CuAAC reaction mix in a humid box under gentle agitation. After incubation, we washed cells or slices three times for 10 min each at room temperature with 1% Tween-20, 0.5 mM EDTA in PBS, pH 7.4, followed by three rinses with PBS, pH 7.4, before immunostaining using standard conditions. We tested AHA and HPG concentrations ranging from 0.1 mM to 4 mM and observed saturation of labeling at a 2 mM concentration without any apparent toxicity or any change in gross cellular morphology (data not shown). Therefore, we used 2 mM AHA or HPG in all subsequent experiments.
For immunolabeling after AHA incorporation and cycloaddition, we treated primary cells sequentially with PBS, blocking solution (0.1% Triton X-100, 2 mg ml −1 BSA, 5% sucrose, 10% normal horse serum in PBS), primary antibody in blocking solution at 4 °C overnight or at room temperature for 2 h, PBS-Tx (0.1% Triton X-100 in PBS), Alexa488-or Alexa568-conjugated secondary antibody (Invitrogen) in blocking solution, PBS-Tx and PBS, and mounted in Gold Prolonged Antifade reagent (Invitrogen) before imaging. For immunolabeling and cycloaddition of AHA-tagged proteins in organotypic cultures, we fixed slices overnight at 4 °C, rinsed extensively several times, blocked and permeabilized overnight in blocking solution before performing CuAAC for at least 12 h at room temperature. We performed immunostaining for MAP2 as described above with extensive washes and prolonged incubation periods with secondary antibodies. We used the following primary antibodies: rabbit anti-microtubule-associated protein 2 (anti-MAP2) polyclonal (1:1,000, Chemicon), mouse anti-MAP2 monoclonal (Sigma, 1:500), mouse anti-Bassoon monoclonal (1:1,000, Stressgen Bioreagents), mouse monoclonal anti-tau (1:400, Chemicon), goat anti-LAT1 (L13) polyclonal (Santa Cruz, 1:100) and rabbit anti-methionyl tRNA synthetase polyclonal (Abcam, 1:500). For secondary antibodies, we used anti-rabbit or antimouse IgG conjugated to Alexa Fluor 488, 568 or 647 (1:500; Invitrogen). local perfusions. Local perfusion experiments were performed with an Olympus IX-70 confocal laser-scanning microscope using Plan-Apochromat ×40, 0.95 numerical aperture air or ×40, 1.0 numerical aperture oil immersion objectives. We excited Alexa 488 with the 488 nm line of an argon ion laser and collected the emitted light between 510 and 550 nm. For restricted treatment of isolated somata or dendritic segments, we used a dual micropipette local delivery system. The delivery micropipette was a typical whole-cell recording pipette with an aperture of ~0.5 μm. We controlled the area of local perfusion by a suction pipette, using it to draw the treatment solution across one or more dendrites and to remove the perfusion solution from the bath. In all microperfusion experiments, we monitored the dimension of the perfusion spot with the fluorescent dye Alexa Fluor 488 hydrazide (1 μg ml −1 , Invitrogen) throughout the duration of the experiment; perfusion spot diameters ranged from 30 to 50 μm. We used only the experiments in which the affected area changed by less than 20% for analysis. In all local perfusion experiments, we maintained the systemat 32 °C with a closed box incubator around the microscope and used several small water pans to keep the system humid. We started somatic perfusions with anisomycin (40 μM) 20 min before bath application of 2 mM AHA or 2 mM AHA plus BDNF (50 ng ml −1 ; 30 min incubation) to decrease somatic translation to minimal levels. After fixation, we performed FUNCAT using 1 mM TRA tag and immunostained for MAP2. We determined the size of the treated area for each soma or dendrite based on Alexa 488 fluorescence integrated across all images (typically 6-10) taken during local perfusion. microscopy and image analysis. Unless otherwise specified, we acquired images with a Zeiss 510 Meta confocal laser scanning microscope. We excited Alexa 488 and 5-carboxyfluorescein with the 488 nm line of an argon ion laser and collected the emitted light between 510 and 550 nm. We excited Texas Red with the 568 nm line of a krypton ion laser and collected the emitted light above 600 nm. In experiments in which two channels were acquired simultaneously, we chose settings to ensure no signal bleed-through between channels. For between-dish comparisons on a given day, we acquired all images using the same settings, without knowledge of the experimental condition during image acquisition. We performed all postacquisition processing and analysis with ImageJ (NIH) and Imaris (Bitplane Scientific Software). To facilitate the analysis of fluorescence signal as a function of distance from the soma, we linearized dendrites and extracted their unprocessed full-frame images using the Straighten plug-in for ImageJ. For the analyses of local perfusion experiments, the unfiltered and otherwise unprocessed stacks of straightened dendrites were analyzed with Imaris to calculate TRA signal intensities per volume. For this we first generated a three-dimensional mask using the corresponding MAP2 stacks of straightened dendrites, and then measured both the MAP2-defined volume and the unprocessed TRA signal intensities across all stacks that were included by the MAP2-defined mask. Data were binned using 10-μm volume segments ('dendritic bins') beginning at the soma.
copper-free click chemistry and single-particle imaging. We performed quantum dot experiments on 8-12 DIV hippocampal neurons. First, we deprived cells of methionine for 30 min in HBS, and then incubated them for 2-4 h at 37 °C, 5% CO 2 , in HBS supplemented with 2 mM AHA, 2 mM AHA plus 40 μM anisomycin or 2 mM methionine. For the click chemistry reaction, we washed and incubated cells in 1 μM DIFO-biotin 29 for 5 min at room temperature. After 5-10 washes, we then incubated coverslips for 1 min at 37 °C with streptavidin-coated quantum dots emitting at 605 nm (1 nM, Invitrogen) in borate buffer (50 mM, pH 8.5)
